BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

783 related articles for article (PubMed ID: 18041415)

  • 1. A comparative study of tar and betamethasone valerate in chronic plaque psoriasis: a study in Thailand.
    Thawornchaisit P; Harncharoen K
    J Med Assoc Thai; 2007 Oct; 90(10):1997-2002. PubMed ID: 18041415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L; Cutler TP; Helander I; Nyfors B; Downes N
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
    Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
    Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasis.
    Khandpur S; Sharma VK
    Clin Exp Dermatol; 2011 Aug; 36(6):613-6. PubMed ID: 21507036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.
    Duweb GA; Abuzariba O; Rahim M; al-Taweel M; Abdulla SA
    Int J Clin Pharmacol Res; 2000; 20(3-4):65-8. PubMed ID: 11314240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of calcipotriol ointment (50 micrograms/g) and 5% coal tar/2% allantoin/0.5% hydrocortisone cream in treating plaque psoriasis.
    Pinheiro N
    Br J Clin Pract; 1997; 51(1):16-9. PubMed ID: 9158266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of psoriasis: comparative study using allantoin coal tar extract combined with hydrocortisone and betamethasone valerate.
    Almeyda J; Wood H
    Br J Clin Pract; 1979 Apr; 33(4):106-8. PubMed ID: 475951
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative evaluation of topical calcipotriol versus coal tar and salicylic acid ointment in chronic plaque psoriasis.
    Singh P; Gupta S; Abidi A; Krishna A
    J Drugs Dermatol; 2013 Aug; 12(8):868-73. PubMed ID: 23986159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mometasone versus betamethasone creams: a trial in dermatoses.
    Wishart JM; Lee IS
    N Z Med J; 1993 May; 106(956):203-5. PubMed ID: 8341439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
    Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
    Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
    Glade CP; Van Erp PE; Van De Kerkhof PC
    Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone.
    Bagel J
    J Drugs Dermatol; 2009 Apr; 8(4):351-7. PubMed ID: 19363853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis.
    Pacifico A; Daidone R; Peris K
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):153-7. PubMed ID: 16441622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study.
    Barikbin B; Givrad S; Yousefi M; Eskandari F
    Clin Exp Dermatol; 2009 Oct; 34(7):776-80. PubMed ID: 19456797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical therapy for psoriasis with the use of augmented betamethasone and calcipotriene on alternate weeks.
    Singh S; Reddy DC; Pandey SS
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):61-5. PubMed ID: 10863225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, randomised, multicentre, parallel group study comparing a 1% coal tar preparation (Exorex) with a 5% coal tar preparation (Alphosyl) in chronic plaque psoriasis.
    Goodfield M; Kownacki S; Berth-Jones J
    J Dermatolog Treat; 2004 Jan; 15(1):14-22. PubMed ID: 14754644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tazarotene cream (0.1%) in combination with betamethasone valerate foam (0.12%) for plaque-type psoriasis.
    Dhawan SS; Blyumin ML; Pearce DJ; Feldman SR
    J Drugs Dermatol; 2005; 4(2):228-30. PubMed ID: 15776784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of safety and efficacy of fluticasone propionate cream, 0.05%, and betamethasone valerate cream, 0.1%, in the treatment of moderate-to-severe psoriasis.
    Callen J
    Cutis; 1996 Feb; 57(2 Suppl):45-50. PubMed ID: 8646870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.